John Drayton Wise - Jan 7, 2025 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief Commercial Officer
Signature
/s/ John Drayton Wise, by Michael A. Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
Jan 7, 2025
Transactions value $
-$735,374
Form type
4
Date filed
1/10/2025, 06:45 PM
Previous filing
May 30, 2024
Next filing
Feb 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $161K +10K +8.16% $16.07 132K Jan 7, 2025 Direct F1, F2
transaction INSM Common Stock Sale -$660K -10K -7.55% $65.98 122K Jan 7, 2025 Direct F1
transaction INSM Common Stock Sale -$192K -2.91K -2.37% $65.87 120K Jan 7, 2025 Direct F3, F4
transaction INSM Common Stock Sale -$26K -392 -0.33% $66.21 119K Jan 8, 2025 Direct F3
transaction INSM Common Stock Award +6.66K +5.59% 126K Jan 8, 2025 Direct F5, F6
transaction INSM Common Stock Sale -$18.8K -287 -0.23% $65.40 126K Jan 10, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00 0 Jan 7, 2025 Common Stock 10K $16.07 Direct F1, F7
transaction INSM Stock Option (right to buy) Award $0 +31.9K $0.00 31.9K Jan 8, 2025 Common Stock 31.9K $65.72 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F3 Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
F4 This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5 Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F6 Each RSU was granted on January 8, 2025 for no consideration.
F7 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
F8 These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.